Fingolimod-d4 hydrochloride

• CAT Number: S000281
• CAS Number: 1346604-90-7
• Molecular Formula: C19H30D4ClNO2
• Molecular Weight: 347.96
• Purity: ≥95%
• Target: Cytoskeleton
• IUPAC Name: 2-amino-1,1,3,3-tetradeuterio-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol;hydrochloride
• InChI: InChI=1S/C19H33NO2.ClH/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22;/h9-12,21-22H,2-8,13-16,20H2,1H3;1H/i15D2,16D2
• InChIKey: SWZTYAVBMYWFGS-JWIOGAFXSA-N
• SMILES: CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl

A fingolimod-d4 hydrochloride（Cat No.:S000281） is a deuterated form of fingolimod hydrochloride, where four hydrogen atoms are replaced with deuterium. This modification enhances its molecular stability, making it invaluable as an internal standard for precise analytical methods like mass spectrometry and NMR spectroscopy. Fingolimod is a sphingosine 1-phosphate receptor modulator used primarily for the treatment of multiple sclerosis. The introduction of deuterium in fingolimod-d4 hydrochloride facilitates more detailed pharmacokinetic and metabolic studies, enabling researchers to gain clearer insights into the drug’s behavior, particularly its absorption, distribution, metabolism, and excretion.